Penthrox USA Update
19 July 2019
Penthrox® USA Update
Medical Developments International Limited (ASX: MVP) advises that it met with the Food and Drug Administration (FDA) in mid-June 2019 in respect to its IND clinical hold letter issued in August 2018.
For the full announcement, please click on the following link: Penthrox USA Update